Prognosis of systemic inflammation at an early stage of cirrhosis using the monocyte-to-lymphocyte ratio during malnutrition risk screening: a prospective cohort study

References

• Irvine KM, Ratnasekera I, Powell EE. Causes and consequences of innate immune dysfunction in cirrhosis. Front Immunol. 2019;10:293.
   PubMed Web of Science ®Google Scholar
• Jepsen P, Younossi ZM. The global burden of cirrhosis: a review of disability-adjusted life-years lost and unmet needs. J Hepatol. 2021;75(Suppl 1):S3–s13.
   PubMed Web of Science ®Google Scholar
• Traub J, Reiss L, Aliwa B. Malnutrition in patients with liver cirrhosis. Nutrients. 2021;13. DOI:10.3390/nu14010013
   PubMed Web of Science ®Google Scholar
• Siddiqui ATS, Parkash O, Hashmi SA. Malnutrition and liver disease in a developing country. World J Gastroenterol. 2021;27:4985–4998.
   PubMed Web of Science ®Google Scholar
• Cederholm T, Jensen GL, Correia M. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38:1–9.
   PubMed Web of Science ®Google Scholar
• Rocha-Ramírez LM, Hernández-Ochoa B, Gómez-Manzo S. Impact of heat-killed lactobacillus casei strain IMAU60214 on the immune function of macrophages in malnourished children. Nutrients. 2020;12(8):2303.
   PubMed Web of Science ®Google Scholar
• Bourke CD, Berkley JA, Prendergast AJ. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol. 2016;37:386–398.
   PubMed Web of Science ®Google Scholar
• Kondrup J, Rasmussen HH, Hamberg O. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22:321–336.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhu Y, Feng Y. Royal free hospital-nutritional prioritizing tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with nutritional risk screening 2002. Br J Nutr. 2020;124(12):1293–1302.
   PubMed Web of Science ®Google Scholar
• Borhofen SM, Gerner C, Lehmann J. The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis. Dig Dis Sci. 2016;61(6):1735–1743.
   PubMed Web of Science ®Google Scholar
• Booi AN, Menendez J, Norton HJ. Validation of a screening tool to identify undernutrition in ambulatory patients with liver cirrhosis. Nutr Clin Pract. 2015;30(5):683–689.
   PubMed Web of Science ®Google Scholar
• Diaz-Martinez J, Campa A, Delgado-Enciso I. The relationship of blood neutrophil-to-lymphocyte ratio with nutrition markers and health outcomes in hemodialysis patients. Int Urol Nephrol. 2019;51(7):1239–1247.
   PubMed Web of Science ®Google Scholar
• Jabłońska B, Pawlicki K, Mrowiec S. Associations between nutritional and immune status and clinicopathologic factors in patients with pancreatic cancer: a comprehensive analysis. Cancers (Basel). 2021;13. DOI:10.3390/cancers14010013
   PubMed Web of Science ®Google Scholar
• Stefaniuk P, Szymczyk A, Podhorecka M. The neutrophil to lymphocyte and lymphocyte to monocyte ratios as new prognostic factors in hematological malignancies - a narrative review. Cancer Manag Res. 2020;12:2961–2977.
   PubMed Web of Science ®Google Scholar
• Cai YJ, Dong JJ, Dong JZ. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure. Aliment Pharmacol Ther. 2017;45:1413–1426.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Pasta L, Morabito A. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10):1180–1193.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Morabito A, D’Amico M. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68(3):563–576.
   PubMed Web of Science ®Google Scholar
• de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43(1):167–176.
   PubMed Web of Science ®Google Scholar
• Costa D, Simbrunner B, Jachs M. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol. 2021;74(4):819–828.
   PubMed Web of Science ®Google Scholar
• Noori N, Kopple JD, Kovesdy CP. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(12):2258–2268.
   PubMed Web of Science ®Google Scholar
• Mohri T, Mohri Y, Shigemori T. Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer. World J Surg Oncol. 2016;14(1):170.
   PubMed Web of Science ®Google Scholar
• Ishigami M, Honda T, Okumura A. Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation. J Gastroenterol. 2008;43:363–368.
   PubMed Web of Science ®Google Scholar
• Martin P, DiMartini A, Feng S. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the study of liver diseases and the American society of transplantation. Hepatology. 2014;59(3):1144–1165.
   PubMed Web of Science ®Google Scholar
• Delis SG, Bakoyiannis A, Biliatis I. Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma. Hpb. 2009;11(4):351–357.
   PubMed Web of Science ®Google Scholar
• Valmasoni M, Pierobon ES, De Pasqual CA. Esophageal cancer surgery for patients with concomitant liver cirrhosis: a single-center matched-cohort study. Ann Surg Oncol. 2017;24(3):763–769.
   PubMed Web of Science ®Google Scholar
• Cholongitas E, Marelli L, Shusang V. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transplant. 2006;12(7):1049–1061.
   PubMed Web of Science ®Google Scholar
• Buderer NM. Statistical methodology: i. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3(9):895–900.
   PubMed Web of Science ®Google Scholar
• Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61(6):1385–1396.
   PubMed Web of Science ®Google Scholar
• Bémeur C, Butterworth RF. Reprint of: nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol. 2015;5:S131–40.
   PubMedGoogle Scholar
• Wang X, Feng H, Hui Y. Neutrophil-to-lymphocyte ratio is associated with malnutrition risk estimated by the royal free hospital-nutritional prioritizing tool in hospitalized cirrhosis. JPEN. 2021;
   Web of Science ®Google Scholar
• Pearson TA, Mensah GA, Alexander RW. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation. 2003;107(3):499–511.
   PubMed Web of Science ®Google Scholar
• Norelli M, Camisa B, Barbiera G. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat Med. 2018;24(6):739–748.
   PubMed Web of Science ®Google Scholar
• Georgiou A, Papatheodoridis GV, Alexopoulou A. Evaluation of the effectiveness of eight screening tools in detecting risk of malnutrition in cirrhotic patients: the KIRRHOS study. Br J Nutr. 2019;122(12):1368–1376.
   PubMed Web of Science ®Google Scholar
• Bischoff SC, Bernal W, Dasarathy S. ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr. 2020;39(12):3533–3562.
   PubMed Web of Science ®Google Scholar
• Lai JC, Tandon P, Bernal W. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the study of liver diseases. Hepatology. 2021;74(3):1611–1644.
   PubMed Web of Science ®Google Scholar
• Buchard B, Boirie Y, Cassagnes L. Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: which tools should we use in clinical practice? Nutrients. 2020;12(1):186.
   PubMed Web of Science ®Google Scholar
• Dupont B, Dao T, Joubert C. Randomized clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice. Aliment Pharmacol Ther. 2012;35(10):1166–1174.
   PubMed Web of Science ®Google Scholar
• Liaskou E, Hirschfield GM. Cirrhosis-associated immune dysfunction: novel insights in impaired adaptive immunity. EBioMedicine. 2019;50:3–4.
   PubMed Web of Science ®Google Scholar
• Quan XQ, Wang RC, Zhang Q. The predictive value of lymphocyte-to-monocyte ratio in the prognosis of acute coronary syndrome patients: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2020;20(1):338.
   PubMed Web of Science ®Google Scholar
• Dupré A, Malik HZ. Inflammation and cancer: what a surgical oncologist should know. Eur J Surg Oncol. 2018;44(5):566–570.
   PubMed Web of Science ®Google Scholar
• Jakab SS, Garcia-Tsao G. Screening and surveillance of varices in patients with cirrhosis. Clinical gastroenterology and hepatology: the official clinical practice. J Am Gastroenterol Assoc. 2019;17:26–29.
   Google Scholar
• Perri RE, Chiorean MV, Fidler JL. A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology. 2008;47(5):1587–1594.
   PubMed Web of Science ®Google Scholar
• Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res. 2018;7. DOI:10.12688/f1000research.13943.1
   PubMedGoogle Scholar